The potential for personalized medicine, combination therapies, and digital health advancements could further revolutionize NAFLD management
Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.
Diabetic Ketoacidosis SGLT2 inhibitors carry a rare but serious risk of euglycemic diabetic ketoacidosis, a condition where DKA occurs without markedly elevated blood sugar
The AP-NORC poll results indicate that even as doctors urge the drugs use, some Americans continue to have concerns about weight-loss drugs, particularly for teens and people who arent struggling with obesity
It was previously approved by the FDA for diagnostic evaluation and treatment of pediatric GH deficiency and is now widely used off-label in research and clinical settings to address adult-onset GH insufficiency and age-related hormonal decline
Mesinovic J, McMillan BL, Shore-Lorenti C, De Courten B, Ebeling RP, Scott D